Generation Bio Price to Sales Ratio 2020-2023 | GBIO

Historical PS ratio values for Generation Bio (GBIO) over the last 10 years. The current P/S ratio for Generation Bio as of April 26, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Generation Bio P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-04-26 2.90 32.01
2023-12-31 1.65 $0.09 18.21
2023-09-30 3.79 $0.05 82.46
2023-06-30 5.50 $0.01 410.35
2023-03-31 4.30 0 0.00
2022-12-31 3.93 0 0.00
2022-09-30 5.31 0 0.00
2022-06-30 6.56 0 0.00
2022-03-31 7.34 0 0.00
2021-12-31 7.08 0 0.00
2021-09-30 25.07 0 0.00
2021-06-30 26.90 0 0.00
2021-03-31 28.46 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.193B $0.006B
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.482B 5.59
Dr Reddy's Laboratories (RDY) India $12.441B 19.67
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.656B 0.00
Bausch Health Cos (BHC) Canada $3.183B 2.48
Amphastar Pharmaceuticals (AMPH) United States $2.009B 13.75
Supernus Pharmaceuticals (SUPN) United States $1.646B 0.00
Taysha Gene Therapies (TSHA) United States $0.447B 0.00
Assembly Biosciences (ASMB) United States $0.069B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00